<unk>  (INN, trade name Cleviprex) is a dihydropyridine calcium channel blocker indicated for the reduction of blood pressure when oral therapy is not feasible or not desirable.<unk>  is used IV only and practitioners titrate this drug to lower blood pressure. It has a half-life of approximately one minute. It is rapidly inactivated by esterases. It was approved by the United States Food and Drug Administration on August 1, 2008.
Clevidipine
Lercanidipine
Lacidipine
Nimodipine
Stanozolol
Nitrendipine
Balsalazide
Nadolol